Subscribe to our newsletter

Japan RA Registry

CorEvitas is now part of Thermo Fisher Scientific. Read More.
8200 +
STUDY VISITS
1900 +
PATIENTS
100 +
RHEUMATOLOGISTS
RA Japan Map

Participating Sites

CorEvitas has clinical sites across Japan and we are always interested in expanding the registry for qualified sites.
LEARN MORE

Outcome measures in the CorEvitas Japan RA Registry.

Among the variables we collect, some of the key outcome measures to inform your research include:

Calculated Outcomes

  • Disease Activity Score (DAS28)
  • Clinical Disease Activity Index (CDAI)
  • Simple Disease Activity Index (SDAI)

Patient Reported Outcomes

  • Euro-QoL Group EQ-5D-5L
  • Japanese version of the Health Assessment Questionnaire (J-HAQ)
  • Patient Global Assessment
  • Pain Visual Analogue Scale
  • Morning Stiffness Visual Analogue Scale
  • Fatigue Visual Analogue Scale
  • Work Productivity and Activity Impairment (WPAI)
  • Healthcare resource utilization

Our Publications

MANUSCRIPTS AND ABSTRACTS

Other Registries

Question about a registry?

Contact Us